Has Kyle Mitchell, MD received payments from drug or device companies?

Yes. Drug and device makers reported $13,106 in general payments to Kyle Mitchell, MD across 35 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kyle Mitchell, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kyle Mitchell, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kyle Mitchell, MD

Neurology · Durham, NCNPI 1659634608

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $10,220 of the $13,106 with a category attached, or 78.0%. Boston Scientific accounts for 90.5% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2023 at $6,256 and has fallen 98.4% since, to $99 in 2025.

$13,106in general payments, 2019–2025

Across 35 payments — averaging $374.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$12K
Medtronic$1K
AbbVie$27
Alkermes, Inc.$22

$307,850in research payments, 2019–2025

Across 37 payments — averaging $8320.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$196K
Surgical Information Sciences, Inc.$112K

What the payments were for

Consulting fees$10,22078%
Travel & lodging$1,89114%
Food & beverage$9958%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	27	$11,861
Medtronic(2 entities)	5	$1,196
AbbVie(2 entities)	2	$27
Alkermes, Inc.	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,106 in reported general payments places this provider in the 80th percentile of 566 neurology providers in North Carolina.

See all neurology providers in North Carolina →

Medicare billing

Part B allowed, 2024

$64,002

Medicare patients

306

Services billed

870

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
NuplazidPimavanserin Tartrate	37	$181,727
RytaryCarbidopa/Levodopa	74	$122,160
Carbidopa-LevodopaCarbidopa/Levodopa	556	$23,364
Entacapone	56	$20,460
Carbidopa-Levodopa ErCarbidopa/Levodopa	185	$8,772
Rasagiline Mesylate	19	$3,112
Primidone	67	$2,858
AmantadineAmantadine Hcl	37	$2,630
Donepezil Hcl	77	$2,192
Ropinirole ErRopinirole Hcl	12	$2,003
Mirtazapine	68	$1,748
Clonazepam	87	$590
Propranolol Hcl ErPropranolol Hcl	15	$542
Propranolol Hcl	28	$525
Pramipexole DihydrochloridePramipexole Di-Hcl	23	$449

Paid to pharmacies, not to this prescriber.

Other neurology in Durham

Kevin KahnDurham$587K
Mark SkeenDurham$562K
Alan FinkelDurham$284K
Natalia GonzalezDurham$220K
Karissa GableDurham$203K
Aatif HusainDurham$146K
Jeffrey GuptillDurham$102K
Nicole GillDurham$92K
Rodney RadtkeDurham$69K
Donald SandersDurham$64K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →